Recent Updates
Recently added Catalysts
HAE Positive Sentiment

Haemonetics to Present at Raymond James 46th Annual Institutional Investors Conference Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will participate in a fireside chat with investors at the Raymond...

Monday, February 24, 2025 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Haemonetics Corporation announced that its President and CEO, Chris Simon, will participate in a fireside chat at the Raymond James 46th Annual Institutional Investors Conference on March 4, 2025. The event will be accessible to the public via a live webcast, with a replay available for 90 days afterward. This participation highlights Haemonetics' commitment to transparency and investor engagement.
Price reaction · baseline $63.02 (2025-02-21 close) · clean, no other HAE news in the window
day 0 close · peak
+4.6%

Market Sentiment Analysis

POSITIVE FACTORS

  • Chris Simon will engage with investors directly.
  • The event allows for public access to the discussion.
  • Haemonetics continues to showcase its commitment to investor relations.

Full Press Release Details

BOSTON , Feb. 24, 2025 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE ) announced that Chris Simon , President and CEO, will participate in a fireside chat with investors at the Raymond James 46th Annual Institutional Investors Conference on Tuesday, March 4, 2025 at 2:50 p.m. ET .
The public may access a live webcast of the fireside chat at Haemonetics' Investor Relations website or at the following link: https://wsw.com/webcast/rj131/hae/1437678 . A replay of the recorded webcast will become accessible 12 hours after the event and will be available for 90 days on Haemonetics' Investor Relations website.
ABOUT HAEMONETICS
Haemonetics (NYSE: HAE ) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com .

Frequently Asked Questions

When will Haemonetics' CEO speak at the conference?

Chris Simon will speak on March 4, 2025, at 2:50 p.m. ET.

How can the public access the fireside chat?

The public can access a live webcast on Haemonetics' Investor Relations website.

Will there be a replay of the event?

Yes, a replay will be available 12 hours after the event for 90 days.

What is the focus of Haemonetics Corporation?

Haemonetics focuses on innovative medical products for blood and plasma collection.

ShareAdd on Google
Tags: HAE Viatris Investor Conferences Healthcare Haemonetics Chris Simon Raymond James investor relations medical products
Last updated: Feb 24, 2025

Biotech snapshot

Cash runway
$248M liquidity · $0M/mo burn
Low dilution risk
Lead asset
SOLXPhase 1
Blood Donors →